Impact of burn injury on hepatic TGF-β1 expression and plasma TGF-β1 levels

Journal of Trauma - Injury, Infection and Critical Care

Volumn 48, Issue 1, 2000, Pages 39-44

  Nishimura, Tetsuro ^a   Nishiura, Teruhiro ^a   DeSerres, Suzan ^a   Nakagawa, Takao ^a   Brenner, David A ^a   Meyer, Anthony A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BURN; CONFERENCE PAPER; CONTROLLED STUDY; HISTOLOGY; INFLAMMATION; INJURY; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0033966197     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. Sporn MB Roberts AB. Transforming growth factor-beta: recent progress and new challenges. J Cell Biol. 1992; 119:1017-1021.
2. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA. 1986;83:4167-4171.
3. Russell WE, Coffey RJ Jr, Ouellette AJ, Moses HL. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA. 1988;85:5126-5130.
4. Russell WE. Transforming growth factor beta (TGF-beta) inhibits hepatocyte DNA synthesis independently of EGF binding and EGF receptor autophosphorylation. J Cell Physiol. 1988;135:253-261.
5. Ponchel F, Puisieux A, Tabone E, et al. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. Cancer Res. 1994;54:2064-2068.
6. Bursch W, Dusterberg B, Schulte-Hermann R. Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate. Arch Toxicol. 1986;59:221-227.
7. Schulte-Hermann R. Tumor promotion in the liver. Arch Toxicol. 1985;57:147-158.
8. Bursch W, Lauer B, Timmermann-Trosiener I, Barthel G, Schuppler J, Schulte-Hermann R. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis. 1984;5:453-458.
9. Boobis AR, Fawthrop DJ, Davies DS. Mechanisms of cell death. Trends Pharmacol Sci. 1989;10:275-280.
10. Wyllie AH, Kerr JF Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-306.
11. Meert KL, Ofenstein JP, Genyea C, Sarnaik AP, Kaplan J. Elevated transforming growth factor-beta concentration correlates with posttrauma immunosuppression. J Trauma. 1996;40:901-906.
12. Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest. 1995;96:447-455.
13. Hultman CS, Cairns BA, deSerres S, Frelinger JA, Meyer AA. Early, complete burn wound excision partially restores cytotoxic T lymphocyte function. Surgery. 1995;118:421-429; discussion 429-430.
14. Wahl SM. Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure. J Clin Immunol. 1992; 12:61-74.
15. Sasaki H, Pollard RB, Schmitt D, Suzuki F. Transforming growth factor-beta in the regulation of the immune response. Clin Immunol Immunopathol. 1992;65:1-9.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
17. Cheng M, Watson PH, Paterson JA, Seidah N, Chretien M, Shiu RP. Pro-protein convertase gene expression in human breast cancer. Int J Cancer. 1997;71:966-971.
18. el-Husseini A el-D, Paterson JA, Shiu RP. Basic fibroblast growth factor (bFGF) and two of its receptors, FGFR1 and FGFR2: gene expression in the rat brain during postnatal development as determined by quantitative RT-PCR. Mol Cell Endocrinol. 1994;104:191-200.
19. Diehl AM, Yin M, Fleckenstein J. et al. Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury. Am J Physiol. 1994;267:G552-G561.
20. Baldwin AS Jr, Azizkhan JC, Jensen DE, Beg AA, Coodly LR. Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts. Mol Cell Biol. 1991;11:4943-4951.
21. Iimuro Y, Nishiura T, Hellerbrand C, et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest. 1998;101:802-811.
22. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N. Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Nail Acad Sci USA. 1988;85:1539-1543.
23. Frank S, Madlener M, Werner S. Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem. 1996;271:10188-10193.
24. Coffey RJ Jr, Kost LJ, Lyons RM, Moses HL, LaRusso NF. Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest. 1987;80:750-757.
25. Zentella A, Weis FM, Ralph DA, Laiho M, Massague J. Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function. Mol Cell Biol. 1991;11:4952-4958.
26. Strain AJ, Hill DJ, Milner RD. Divergent action of transforming growth factor beta on DNA synthesis in human foetal liver cells. Cell Biol Int. 1986;10:855-860.
27. Wollenberg GK, Semple E, Quinn BA, Hayes MA. Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-beta. Cancer Res. 1987;47:6595-6599.
28. Czaja MJ, Weiner FR, Flanders KC, et al. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol. 1989;108:2477-2482.
29. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest. 1990;85:1833-1843.
30. Nakatsukasa H, Evarts RP, Hsia CC, Thorgeirsson SS. Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver. Lab Invest. 1990;63:171-180.
31. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol. 1991;139:1221-1229.
32. Annoni G, Weiner FR, Zern MA. Increased transforming growth factor-beta 1 gene expression in human liver disease. J Hepatol. 1992;14:259-264.
33. Sanderson N, Factor V, Nagy P, et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA. 1995;92:2572-2576.
34. Bedossa P, Paradis V. Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis. J Hepatol. 1995;22:37-42.
35. Czaja MJ, Flanders KC, Biempica L, Klein C, Zern MA, Weiner FR. Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in acute liver injury. Growth Factors. 1989;1:219-226.
36. Migheli A, Cavalla P, Marino S, Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol. 1994;53:606-616.
37. Wyllie AH Apoptosis (the 1992 Frank Rose Memorial Lecture). Br J Cancer. 1993;67:205-208.
38. Nakamura T, Tomita Y, Hirai R, Yamaoka K, Kaji K, Ichihara A. Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun. 1985;133:1042-1050.
39. Carr BI, Hayashi I, Branum EL, Moses HL. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor. Cancer Res. 1986;46:2330-2334.
40. McMahon JB, Richards WL, del Campo AA, Song MK, Thorgeirsson SS. Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res. 1986;46:4665-4671.
41. Oberhammer FA, Pavelka M, Sharma S, et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci USA. 1992;89:5408-5412.
42. Oberhammer F, Bursch W, Tiefenbacher R, et al. Apoptosis is induced by transforming growth factor-beta 1 within 5 hours in regressing liver without significant fragmentation of the DNA. Hepatology. 1993;18:1238-1246.
43. Takiya S, Tagaya T, Takahashi K, et al. Role of transforming growth factor beta 1 on hepatic regeneration and apoptosis in liver diseases. J Clin Pathol. 1995; 48:1093-1097.
44. Oberhammer F, Bursch W, Parzefall W, et al. Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. Cancer Res. 1991;51:2478-2485.
45. Kerr JF. Shrinkage necrosis: a distinct mode of cellular death. J Pathol. 1971;105:13-20.
46. Walker NI, Harmon BV, Gobe GC, Kerr JF. Patterns of cell death. Methods Achiev Exp Pathol. 1988;13:18-54.
47. Lockshin RA, Zakeri ZF. Programmed cell death: new thoughts and relevance to aging. J Gerontol. 1990;45:B135-B140.
48. Bursch W, Oberhammer F, Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci. 1992;13:245-251.
49. Nishiura T, Nishimura T, deSerres S, et al. Gene expression, cytokine and enzyme activation in the liver after burn injury. J Burn Care Rehabil. In press.